
Thursday, May 08, 2025 1:54:53 PM
<<<<< we creep on old posts by other posters that disagree with thyself >>>>> Pointing out false information is not "creeping", it is called 'fact checking'
* BIEL's Moneyback Guarantee is a Scam. Actually, the Guarantee is quite clear, you receive both a 720 hour and a 7 day device, use the 7 day device first, if you are not satisfied with the pain relief return the unused 720 hour device for a full refund..
* Phantom Limb Pain is not Real Pain. Actually, the brain receives the same pain signals in Phantom Pain as actual pain.
* IBEX and St John's Forgoing Interest does not mean 'Giving it Up'. Actually, 'to give something up' is the definition of Forgoing
* Mundipharma never produced any sales for ActiPatch. Actually, Mundipharma placed ActiPatch in hundreds of Australian Pharmacies and had signed up for additional distribution in 5 Asian countries before their parent company, Purdue, declared BK due to Opioid Crisis Lawsuits
* The KT Wave was another BIEL failure. Actually, BIEL operated as an OEM supplier for KT, BIEL produced the device, period. The Wave was KT's product and they controlled all distribution/marketing decisions, KT specified a 250 hour battery for the Wave, the $34.95 pricing, and ignoring the 'chronic pain market'
* BIEL is paying hundreds of thousands of dollars in interest on convertible loans each year. Actually, the interest on convertible loans is added to the original amount loaned each year and not paid until the loan is converted.
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM